TY - JOUR
T1 - Using evidence reports
T2 - Progress and challenges in evidence-based decision making
AU - Helfand, Mark
N1 - Copyright:
Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2005/1
Y1 - 2005/1
N2 - This Perspective describes the advantages of using systematic evidence reviews in preferred drug deliberations. By involving decisionmakers in defining the scope, evidence reports help focus deliberations on clinically important questions and reduce the likelihood of bias. They define the limits of the evidence and the magnitude of differences among compared drugs; however, decisionmakers must consider other factors and apply their values to their decisions in an explicit, defensible manner. GRADE, an international consortium of systematic-review developers and users, is seeking to improve the process of incorporating considerations other than the strength of evidence in making decisions that are evidence based.
AB - This Perspective describes the advantages of using systematic evidence reviews in preferred drug deliberations. By involving decisionmakers in defining the scope, evidence reports help focus deliberations on clinically important questions and reduce the likelihood of bias. They define the limits of the evidence and the magnitude of differences among compared drugs; however, decisionmakers must consider other factors and apply their values to their decisions in an explicit, defensible manner. GRADE, an international consortium of systematic-review developers and users, is seeking to improve the process of incorporating considerations other than the strength of evidence in making decisions that are evidence based.
UR - http://www.scopus.com/inward/record.url?scp=12844257555&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=12844257555&partnerID=8YFLogxK
U2 - 10.1377/hlthaff.24.1.123
DO - 10.1377/hlthaff.24.1.123
M3 - Review article
C2 - 15647222
AN - SCOPUS:12844257555
SN - 0278-2715
VL - 24
SP - 123
EP - 127
JO - Health Affairs
JF - Health Affairs
IS - 1
ER -